Search

Search Results

• 

  Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas

  Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Masao Akagi

  2021-07-02

  Published: 2 July 2021

  2109

  PDF: 689

  HTML: 21
• 

  Immunohistochemical expression and clinicopathological assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in highly aggressive soft tissue sarcomas

  Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Ryosuke Kakinoki, Masao Akagi

  2022-04-22

  Published: 22 April 2022

  761

  PDF: 544

  HTML: 17
• 

  Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors

  Kazuhiko Hashimoto, Shunji Nishimura, Yu Shinyashiki, Tomohiko Ito, Ryosuke Kakinoki, Masao Akagi

  2023-04-26

  Published: 26 April 2023

  420

  PDF: 328

  HTML: 15
• 

  Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma

  Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Naohiro Oka, Ryosuke Kakinoki, Masao Akagi

  2022-06-23

  Published: 23 June 2022

  1034

  PDF: 587

  HTML: 18
• 

  Tumor cells-derived exosomal PD-L1 promotes the growth and invasion of lung cancer cells in vitro via mediating macrophages M2 polarization

  Xiangjun Lu, Jian Shen, Siyuan Huang, Dongdong Liu, Haitao Wang

  2023-08-01

  Published: 1 August 2023

  715

  PDF: 519

  HTML: 10
• 

  Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment

  Tao Wu, Shikui Wu, Hui Gao, Haolei Liu, Jun Feng, Ge Yin

  2024-10-23

  Published: 23 October 2024

  374

  PDF: 81

  HTML: 0